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Abstract: Inadequate magnesium (Mg) intake is associated with lower physical performance, but
the relationship with frailty in older people is unclear. Therefore, we aimed to investigate whether
higher dietary Mg intake is associated with a lower risk of frailty in a large cohort of North American
individuals. Details regarding Mg intake were recorded through a food-frequency questionnaire
(FFQ) and categorized as greater than/equal to Recommended Dietary Allowance (RDA) vs. lower.
Frailty was defined using the Study of Osteoporotic Fractures index. Multivariable Cox’s regression
analyses, calculating hazard ratios (HRs) with 95% confidence intervals (CIs), were undertaken by
sex. In total, 4421 individuals with knee osteoarthritis or who were at high risk without frailty at
baseline (mean age: 61.3, females = 58.0%) were followed for 8 years. After adjusting for 11 potential
baseline confounders, reaching the RDA for Mg lowered risk of frailty among men (total n = 1857,
HR = 0.51; 95% CI: 0.26–0.93), whilst no significant associations were found in women (total n = 2564).
Each 100 mg of dietary Mg intake at baseline corresponded to a 22% reduction in men (HR = 0.78;
95% CI: 0.62–0.97; p = 0.03), but not in women (HR = 1.05; 95% CI: 0.89–1.23). In conclusion, higher
dietary Mg intake appears to reduce the risk of frailty in men, but not in women.
Keywords: frailty; magnesium; older adults; Osteoarthritis Initiative
1. Introduction
Frailty is a clinical syndrome that identifies older subjects with increased vulnerability to stress [1].
Frailty is a common condition, with an estimated prevalence of about 10% among community-dwelling
older people [2], with even higher numbers reported among older people in long-term care [3].
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Frailty has been associated with an increased risk of several deleterious outcomes, including disability,
falls, hospitalization, institutionalization, and death [4], but recent literature suggests that frailty might
also be associated with a higher risk of metabolic [5], psychiatric [6], and cardiovascular disease [7].
It is widely assumed that early interventions for frailty, particularly in the pre-frailty state, might
improve quality of life, reducing adverse outcomes and associated costs of care [8].
The pathophysiology of frailty is complex and multi-factorial. However, nutrition is an important
modifiable factor in its onset and therefore a clear target for intervention [9]. It has been reported
that frailty is associated with lower levels of several micronutrients, including vitamins and minerals,
such as magnesium (Mg) [10]. Mg has a pivotal role in muscle function and it is essential for energy
metabolism, transmembrane transport, and muscle relaxation and contraction [11]. In humans, lower
Mg levels seem to be associated with a significant lower muscular function [12,13]. This effect
could be due to several mechanisms, including higher oxidative stress [14], and inflammatory [15],
and insulin-resistance [16] pathways. However, to the best of our knowledge, no longitudinal study
has reported a possible association between Mg and the incidence of frailty. Understanding if low Mg
is associated with higher risk of frailty is of importance, since the deficiency of Mg is easily reversible
with appropriate dietary suggestions or supplementation [17].
Given this background, the aim of the present study was to investigate the association between
dietary Mg intake at baseline and the onset of frailty in a large cohort of North American people over
a follow-up period of 8 years. Since previous literature has reported that Mg is effective in improving
physical function, we hypothesized that subjects with a higher Mg intake would be at lower risk of
developing frailty over time.
2. Materials and Methods
2.1. Data Source and Subjects
Data were obtained from the Osteoarthritis Initiative (OAI) database, available for public access
at http://www.oai.ucsf.edu/ [18]. The specific datasets utilized were registered during the baseline
and screening evaluations (V00) and each database reported data on frailty until 96 months from
baseline (V10). Patients at high risk of knee osteoarthritis (OA) were recruited at four clinical centers
(Baltimore, MD, USA; Pittsburgh, PA, USA; Pawtucket, RI, USA; and Columbus, OH, USA) between
February 2004 and May 2006.
All the participants provided written informed consent. The OAI study protocol was approved by
the institutional review board of the OAI Coordinating Center, University of California, San Francisco.
2.2. Baseline Dietary Magnesium Intake (Exposure)
Dietary Mg intake was obtained through a food frequency questionnaire recorded during baseline
visit of the OAI [19]. Since this questionnaire included data on Mg supplementation, this intake
was also considered. Then, the population was categorized in two main groups (consumption equal
to/greater than or less than the corresponding Recommended Dietary Allowance, RDA) using the
cut-offs of 420 mg for men and 320 mg for women, as suggested by the Institute of Medicine (IOM) [20].
2.3. Incident Frailty (Outcome)
The study’s outcome of interest was incident frailty. Frailty was assessed as outcome at wave
1 (12 months), 3 (24 months), 5 (36 months), 6 (48 months), 8 (72 months) and 10 (96 months).
In agreement with the Study of Osteoporotic Fracture (SOF) index and other studies performed
through the OAI [21–25], frailty was defined as the presence of at least 2 of the following 3 criteria:
(1) weight loss ≥5% between baseline and any follow-up examination (since no information regarding
weight changes were available at baseline, we considered those with a body mass index (BMI) of
<20 kg/m2 to fulfill this criteria only for baseline); (2) the inability to rise from a chair five times without
arm support (poor chair stand time); and (3) poor physical performance based on Question 10 of the
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SF12 questionnaire, i.e., responding to the question “in the past 4 weeks, did you feel full of energy?”
with either “A little of the time” or “none of the time”.
2.4. Covariates
Other than the number frailty criteria at baseline (categorized as one vs. none), we identified
several potential confounders at baseline in the association between Mg supplementation and frailty,
including: daily energy intake (in kcal/day); BMI (measured by a trained nurse); physical activity
evaluated using the Physical Activity Scale for the Elderly (PASE) [26]; depressive symptoms evaluated
through the Center for Epidemiologic Studies Depression Scale [27]; race (whites vs. others); smoking
habits (current/previous vs. never smokers); educational level (college degree vs. below) and yearly
income (< or ≥US$50,000 or missing data). Validated general health measures of self-reported
comorbidities were assessed using the modified Charlson co-morbidity score [28].
2.5. Statistical Analyses
Since the interaction sex by dietary Mg intake at baseline with incident frailty as outcome was
significant (p < 0.0001), the data are reported by sex.
Normal distributions of continuous variables were tested using the Kolmogorov–Smirnov test.
Data are shown as means± standard deviations (SD) for quantitative measures, and percentages for all
discrete variables. The difference in baseline characteristics between those reaching the corresponding
RDA or not was tested by the independent t-test for continuous variables and the chi-square test for
categorical ones.
Cox’s regression analysis was used to assess the strength of the association between Mg intake at
baseline and the onset of frailty during follow-up. Significantly different factors with respect to those
reaching or not reaching the corresponding RDA in at least one sex or factors significantly associated
with incident frailty at univariate analysis in at least one sex were included. Multi-collinearity among
covariates was assessed using the variance inflation factor (VIF), with a score of 2 leading to the
exclusion of a variable, but no parameter was excluded for this reason.
The basic model was adjusted for age. In the fully-adjusted model the variables used
were: age (as a continuous variable); race (whites vs. others); BMI (as a continuous variable);
education (college degree vs. below); smoking habits (current and previous smokers vs. others);
yearly income (categorized as ≥ or <US$50,000 or missing data); Physical Activity Scale for Elderly
score (as a continuous variable); Charlson co-morbidity index (as a continuous variable); Center
for Epidemiologic Studies Depression Scale (as a continuous variable); number of frailty indexes at
baseline (one vs. none); and total energy intake (in kcal/day). The proportional hazard assumption was
verified considering Schoenfeld’s residuals of the covariates [29]. Cox’s regression analysis estimates
were reported as hazard ratios (HRs) with 95% confidence intervals (CIs). A similar analysis was run
using Mg intake as continuous variable, with increases in 100 mg.
Several sensitivity analyses were conducted evaluating the interaction between dietary Mg at
baseline and selected factors (i.e., age below or greater than/equal to 65 years, overweight/obese vs.
normal weight, yearly income, sex, race, education, smoking habits, yearly income, and number of
frailty indexes at baseline categorized as one vs. none) in the association with frailty, but only sex
emerged as moderator of our findings (p < 0.05 for the interaction).
All the analyses were performed using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA).
All statistical tests were two-tailed and statistical significance was assumed for a p-value < 0.05.
3. Results
3.1. Sample Selection
The OAI dataset initially included a total of 4796 American participants. Among them,
22 participants were excluded since they were already frail at baseline and another 353 were excluded
Nutrients 2017, 9, 1253 4 of 9
since they did not provide data regarding frailty during follow-up, resulting in a final sample of
4421 participants.
3.2. Descriptive Characteristics
Of the 4421 participants included, 1857 were males and 2564 were females, with a mean age of
61.3 years (±9.2 years; range: 45–79). Only 819 (233 men and 586 women; =18.5% of the baseline
population; 12.5 vs. 22.9% in men and women, p < 0.0001) reached the corresponding RDA, even
though 2991 participants (=67.7%) took Mg supplementation.
Table 1 shows the participants’ characteristics by their Mg intake at baseline categorized as
reaching the corresponding RDA or not, by sexes. In both men and women, people reporting a dietary
Mg intake equal to/greater than the corresponding RDA were more physically active (p = 0.03 for
both comparisons), whilst no significant differences emerged in terms of co-morbidities or depressive
symptoms (Table 1). Finally, no significant differences emerged in terms of people reporting poor
physical performance, poor chair stand time, or weight loss between people reaching the Mg RDA or
not in both sexes (Table 1).
3.3. Dietary Magnesium Intake and Incident Frailty
During the 8-year follow-up, 362 subjects (120 men and 242 women; 8.2% of the baseline
population) developed frailty corresponding to a global incidence rate of 12 (95% CI: 10–13)/1000
persons-year. Among the singular criteria, the most frequent criterion during follow-up was poor chair
stand time (n = 780, 17.6%), followed by poor physical performance (n = 503, 11.4%), and weight loss
(n = 19, 0.4%).
Table 2 shows the association between dietary Mg intake at baseline and incident frailty at
follow-up. In men, the incidence of frailty among those reaching the corresponding RDA was
significantly lower than for those not reaching this cut-off (6, 95% CI: 3–12 vs. 10, 95% CI: 8–12/1000
persons-year; p = 0.03), whilst no significant differences emerged for women (14, 95% CI: 12–16 vs. 16,
95% CI: 12–20/1000 persons-year; p = 0.36). After adjusting for 11 potential confounders at baseline,
men reaching the RDA had a significant lower risk of frailty of about 49% (HR = 0.51; 95% CI: 0.26–0.93;
p = 0.03) (Table 2; Figure 1), whilst no significant differences emerged for women (HR = 1.02; 95% CI:
0.71–1.46; p = 0.92) or in the sample as whole (HR = 0.88; 95% CI: 0.65–1.20; p = 0.43).
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Table 1. Characteristics of the participants classified according to their baseline dietary magnesium intake.
Men Women
Greater Than/Equal
to RDA (n = 233)
Less than RDA
(n = 1624) p-Value
a Greater Than/Equal
to RDA (n = 586)
Less than RDA
(n = 1978) p-Value
a
General characteristics
Age (years) 61.5 (9.0) 60.9 (9.5) 0.37 62.0 (8.8) 61.4 (9.0) 0.13
Energy intake (kcal/day) 2313 (701) 1488 (523) <0.0001 1760 (553) 1143 (376) <0.0001
PASE (points) 187 (96) 174 (86) 0.03 156 (80) 149 (75) 0.03
White race (n, %) 193 (82.8) 1388 (85.6) 0.28 456 (77.9) 1516 (76.6) 0.54
Smoking (previous/current) (n, %) 116 (50.2) 805 (49.8) 0.94 262 (44.9) 894 (45.4) 0.85
Graduate degree (n, %) 87 (37.3) 596 (36.8) 0.89 146 (24.9) 517 (26.2) 0.59
Yearly income (>US$50,000) 79 (33.9) 478 (29.4) 0.17 292 (50.2) 953 (48.2) 0.40
Medical conditions
BMI (kg/m2) 28.2 (4.2) 28.9 (4.1) 0.08 28.5 (5.1) 28.6 (5.3) 0.67
CES-D (points) 6.3 (6.7) 5.9 (6.4) 0.35 6.9 (6.9) 7.0 (7.2) 0.61
Charlson co-morbidity index (points) 0.5 (1.1) 0.4 (0.9) 0.22 0.4 (0.8) 0.4 (0.8) 0.94
Frailty items
Poor physical performance (n, %) 25 (10.8) 146 (9.0) 0.40 68 (11.6) 251 (12.7) 0.52
Poor chair stand time (n, %) 2 (0.9) 10 (0.6) 0.66 7 (1.2) 13 (0.7) 0.19
Weight loss (n, %) 3 (1.3) 11 (0.7) 0.40 23 (3.9) 62 (3.1) 0.36
Notes: The data are presented as means (with standard deviations) for continuous variables and numbers (with percentages) for the first and the fourth quartiles. a p values were calculated
using the independent t-test for continuous variables and the chi-square test for categorical parameters. Magnesium RDAs were categorized using the cut-offs of 420 mg for men and
320 for women. Abbreviations: CES-D: Center for Epidemiologic Studies Depression Scale; PASE: Physical Activity Scale for the Elderly; BMI: body mass index; RDA: Recommended
Dietary Allowance.
Nutrients 2017, 9, 1253 6 of 9
Modelling dietary Mg intake as a continuous variable and after adjusting for the potential
confounders mentioned before, each increase in 100 mg of dietary Mg intake at baseline corresponded
to a significant reduction in frailty incidence of 22% in men (HR = 0.78; 95% CI: 0.62–0.97; p = 0.03), but
not in women (HR = 1.05; 95% CI: 0.89–1.23; p = 0.59) or in the population as whole (HR = 0.95; 95% CI:
0.83–1.08; p = 0.40).
Table 2. Association between dietary magnesium intake and incidence of frailty.
Incidence (95% CI) for
1000 Persons-Year
Basic Adjusted
a HR (95% CI) p Value
Fully Adjusted
b HR (95% CI) p Value
Men
Greater than the RDA 10 (8–12) 1 (reference) 1 (reference)
Greater than/equal to the RDA 6 (3–12) 0.70 (0.38–0.95) 0.03 0.51 (0.26–0.93) 0.03
Women
Less than the RDA 14 (12–16) 1 (reference) 1 (reference)
Greater than/equal to the RDA 16 (12–20) 1.13 (0.84–1.51) 0.43 1.02 (0.71–1.46) 0.92
Notes: All the data are presented as hazard ratios (HRs) with their 95% confidence intervals. a The basic adjusted
model included as a covariate only age. b The fully-adjusted model included as covariates: age (as continuous);
race (whites vs. others); body mass index (as continuous); education (degree vs. others); smoking habits (current
and previous vs. others); yearly income (categorized as ≥ or <US$50,000 and missing data); Physical Activity
Scale for Elderly score (as a continuous variable); Charlson co-morbidity index; CES-D: Center for Epidemiologic
Studies Depression Scale; number of frailty indexes at baseline (one vs. none); and total energy intake (kcal/day).
Abbreviations: CI: confidence interval; HR: hazard ratio; RDA: Recommended Dietary Allowance.
4. Discussion
To the best of our knowledge, the current study is the first to investigate the relationship between
dietary and supplementary Mg intake and incident frailty. In summary, the present study involving
a large number of persons living in North America found that higher baseline Mg intake is associated
with a lower risk of frailty in men, but not in women, after 8 years of follow-up. The risk of frailty in
men reaching the RDA was almost halved and each increase in 100 mg of Mg intake decreased the risk
of frailty by about 22%.
At baseline, no significant differences emerged between people reaching or not the RDA in both
sexes in terms of potential risk factors for frailty, such as age, co-morbidities, or the presence of any
frailty item. However, people reporting higher Mg intake were more physically active (as shown by
higher PASE scores) and this probably played a role in the lower development of frailty in subjects
reaching the corresponding RDA for Mg. However, it should be noted that our analyses were adjusted
for this factor, suggesting that appropriate Mg intake can have an additional effect on frailty risk.
Another important consideration is the large number of people not reaching an appropriate intake
of Mg. Our data, even if collected in a special population (i.e., people with knee OA or at higher
risk of this condition), are similar to those collected in other American surveys. Using data from the
NHANES (National Health and Nutrition Examination Survey) study, average intakes of Mg from
food alone were higher among users of dietary supplements (350 mg for men and 267 mg for women)
than among non-users (268 mg for men and 234 for women), but were still broadly insufficient [30].
Other surveys reported that almost half of the North American population consumed less than the
required amount of magnesium from food in 2005–2006, and the figure was down from 56% in
2001–2002 [31]. Collectively, these data suggest that, despite the widespread use of Mg supplements,
dietary Mg intake is insufficient in the American population, likely due to low consumption of green
leafy vegetables, legumes, nuts, seeds, and whole grains [32], good sources of dietary Mg.
It is widely known that poor nutritional status is associated with the onset of frailty [9,33].
However, the possible association between Mg intake was poorly explored and the data available
mainly derived from the literature regarding Mg and physical function [34]. Altogether, the previous
findings available showed that higher Mg levels are associated with better physical function [11–13].
However, the design of previous studies (i.e., either cross-sectional or small randomized controlled
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trials) limits the strength of their findings. Thus, the findings from this longitudinal study involving
more than 4000 participants substantially advance our understanding on this topic.
A point of importance is that higher Mg supplementation is associated with lower incidence of
frailty in men, but not in women. We can hypothesize that since frailty has different prevalence and
incidence between men and women [35,36], the risk factors for frailty (including nutritional factors)
are probably different. Unfortunately, there was inadequate data to confirm which specific risk factors
may differ between the sexes. However, with regards to Mg, it is known that women have lower Mg
intake than men, although it is still debated if a different grade of absorption exists between sexes [37],
leading to a different effect on muscle function. Thus, more studies are needed to better identify and
understand the different roles of Mg in determining frailty between sexes.
The present findings should be considered within the limitations of the study. First, we had no
data about Mg status, except for dietary Mg. Even if the best method for the assessment of Mg status
is still equivocal [38,39], it would be interesting to assess if other parameters of Mg status can lead to
different results. Second, we used a slightly different definition of frailty at baseline with respect to the
one used at the follow-up, particularly with respect to weight loss. Unfortunately, no data regarding
weight changes were available in the OAI at baseline and it is possible that some frail individuals at
baseline were included in our analysis. Third, the participants of the OAI may not be representative
of the general population, due to the inclusion/exclusion criteria of this study. Fourth, the inherent
changes of Mg during time were not recorded and, consequently, it is not possible to assess the role
of dietary Mg intake over time in the onset of frailty. Finally, the data regarding co-morbidities were
self-reported and this can introduce another bias in our results.
5. Conclusions
In conclusions, our data suggests that higher dietary Mg intake is associated with a lower risk of
frailty in men, but not in women, suggesting important sex differences in this potential relationship.
Since low Mg intake is prevalent in the North American population, other studies are needed to see if
Mg supplementation could be associated with lower risk of frailty in older people.
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